1. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol. 2003; 111:1095–1098.
2. Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, Spector S, Maurer M. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011; 128:567–573.e1.
3. Maurer M, Rosén K, Hsieh HJ, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013; 368:924–935.
4. Asero R. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Ann Allergy Asthma Immunol. 1999; 82:554–558.
5. Di Lorenzo G, Leto-Barone MS, La Piana S, Seidita A, Rini GB. Chronic spontaneous urticaria: an autoimmune disease? A revision of the literature. Clin Exp Med. 2013; 13:159–164.
6. Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol. 2012; 129:1307–1313.
7. Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol. 1983; 119:636–640.
8. Doutre MS. Chronic urticaria and thyroid auto-immunity. Clin Rev Allergy Immunol. 2006; 30:31–37.
9. Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol. 2005; 5:408–412.
10. Kim MA, Park HS. Highly cytokinergic IgE antibodies and autoimmune mechanisms. Allergy Asthma Immunol Res. 2012; 4:311–312.
11. Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? PLoS One. 2011; 6:e14794.
12. Ye YM, Jin HJ, Hwang EK, Nam YH, Kim JH, Shin YS, Park HS. Co-existence of chronic urticaria and metabolic syndrome: clinical implications. Acta Derm Venereol. 2013; 93:156–160.
13. Gershwin LJ, Netherwood KA, Norris MS, Behrens NE, Shao MX. Equine IgE responses to non-viral vaccine components. Vaccine. 2012; 30:7615–7620.
14. Nam YH, Hwang EK, Ban GY, Jin HJ, Yoo HS, Shin YS, Ye YM, Nahm DH, Park HS, Lee SK. Immunologic evaluation of patients with cefotetan-induced anaphylaxis. Allergy Asthma Immunol Res. 2015; 7:301–303.
15. Altrich ML, Halsey JF, Altman LC. Comparison of the in vivo autologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria. Allergy Asthma Proc. 2009; 30:28–34.
16. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999; 140:446–452.
17. Grattan CE. Autoimmune urticaria. Immunol Allergy Clin North Am. 2004; 24:163–181. v
18. Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, Black AK, Stingl G, Greaves MW, Barr RM. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol. 2002; 110:492–499.
19. Ye YM, Yang EM, Yoo HS, Shin YS, Kim SH, Park HS. Increased level of basophil CD203c expression predicts severe chronic urticaria. J Korean Med Sci. 2014; 29:43–47.
20. Kessel A, Helou W, Bamberger E, Sabo E, Nusem D, Panassof J, Toubi E. Elevated serum total IgE: a potential marker for severe chronic urticaria. Int Arch Allergy Immunol. 2010; 153:288–293.
21. Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D, Panasoff J. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy. 2004; 59:869–873.
22. Toubi E, Adir-Shani A, Kessel A, Shmuel Z, Sabo E, Hacham H. Immune aberrations in B and T lymphocytes derived from chronic urticaria patients. J Clin Immunol. 2000; 20:371–378.
23. Testa A, Castaldi P, Fant V, Fiore GF, Grieco V, De Rosa A, Pazardjiklian MG, De Rosa G. Prevalence of HCV antibodies in autoimmune thyroid disease. Eur Rev Med Pharmacol Sci. 2006; 10:183–186.